Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about P2RY1 AND P2RX7: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
| Name | P2RY1 AND P2RX7 |
graph TD
P2RY1_AND_P2RX7[P2RY1 AND P2RX7]
P2RY1_AND_P2RX7 -->|debate_co_mention| PIEZO1[PIEZO1]
P2RY1_AND_P2RX7 -->|debate_co_mention| PIEZO1_and_KCNK2[PIEZO1 and KCNK2]
P2RY1_AND_P2RX7 -->|debate_co_mention| SOAT1[SOAT1]
P2RY1_AND_P2RX7 -->|debate_co_mention| TET2[TET2]
P2RY1_AND_P2RX7 -->|implicated in| neurodegeneration[neurodegeneration]
P2RY1_AND_P2RX7 -->|data_in| benchmark_ot_ad_answer_key_P2R[benchmark_ot_ad_answer_key:P2RY1 AND P2RX7]
h_0758b337[h-0758b337] -->|targets| P2RY1_AND_P2RX7
DGAT1_and_SOAT1[DGAT1 and SOAT1] -->|debate_co_mention| P2RY1_AND_P2RX7
HK2[HK2] -->|debate_co_mention| P2RY1_AND_P2RX7
MIRO1[MIRO1] -->|debate_co_mention| P2RY1_AND_P2RX7
P2RY1[P2RY1] -->|debate_co_mention| P2RY1_AND_P2RX7
BMAL1[BMAL1] -->|co_associated_with| P2RY1_AND_P2RX7
benchmark_ot_ad_answer_key_P2R -->|data_in| P2RY1_AND_P2RX7| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:P2RY1 AND P2RX7 | data_in | dataset_row | 0.00 |
| PIEZO1 | debate_co_mention | gene | 0.45 |
| PIEZO1 and KCNK2 | debate_co_mention | gene | 0.45 |
| SOAT1 | debate_co_mention | gene | 0.45 |
| TET2 | debate_co_mention | gene | 0.45 |
| neurodegeneration | associated_with | disease | 0.40 |
| neurodegeneration | implicated_in | disease | 0.40 |
| TET2 | co_associated_with | gene | 0.40 |
| PIEZO1 and KCNK2 | co_associated_with | gene | 0.40 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:P2RY1 AND P2RX7 | data_in | dataset_row | 0.00 |
| h-0758b337 | targets | hypothesis | 0.50 |
| HK2 | debate_co_mention | gene | 0.45 |
| MIRO1 | debate_co_mention | gene | 0.45 |
| P2RY1 | debate_co_mention | gene | 0.45 |
| DGAT1 and SOAT1 | debate_co_mention | gene | 0.45 |
| DGAT1 and SOAT1 | co_associated_with | gene | 0.40 |
| MIRO1 | co_associated_with | gene | 0.40 |
| HK2 | co_associated_with | gene | 0.40 |
| BMAL1 | co_associated_with | gene | 0.40 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Purinergic Signaling Polarization Control | 0.713 | neurodegeneration | Astrocyte reactivity subtypes in neurode |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.741
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| s:** - GPR32 knockout in microglia should worsen neuroinflammation if | falsification | Neuroinflammation | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Proposed experiment from debate on Synaptic pruning by microglia in ea | falsification | Neuroinflammation | 0.400 | 0.50 | mouse | proposed | $240,000 |
| Endocannabinoid System Dysfunction Validation in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Purinergic Signaling Dysfunction Validation in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Purinergic signaling elements are correlated with coagulation players in periphe [PMID:35091759] | Schultz IC, Bertoni APS, Wink MR | J Mol Med (Berl) | 2022 | 1 |
| Purinergic Receptors in the Airways: Potential Therapeutic Targets for Asthma? [PMID:35386996] | Thompson RJ, Sayers I, Kuokkanen K, Hall | Front Allergy | 2021 | 1 |
| Variation in glucose homeostasis traits associated with P2RX7 polymorphisms in m [PMID:25719930] | Todd JN, Poon W, Lyssenko V, Groop L, Ni | J Clin Endocrinol Metab | 2015 | 1 |
| CSF ATP levels correlate with Alzheimer's disease severity and predict progressi [PMID:synthetic_4] | Unknown | JAMA Neurol | 2024 | 0 |
| Astrocyte phenotype switching controlled by purinergic receptor balance regulate [PMID:synthetic_1] | Unknown | Nature Neuroscience | 2023 | 0 |
| P2Y1 agonist enhances astrocyte-mediated neuroprotection via BDNF upregulation [PMID:synthetic_3] | Unknown | Glia | 2023 | 0 |
| Astrocyte phenotype heterogeneity may not fit simple A1/A2 binary classification [PMID:synthetic_8] | Unknown | Cell | 2023 | 0 |
| P2X7 antagonists failed to show efficacy in depression trials despite target eng [PMID:synthetic_6] | Unknown | Mol Psychiatry | 2022 | 0 |
| P2X7 antagonist reduces amyloid pathology and preserves cognition in APP/PS1 mic [PMID:synthetic_2] | Unknown | Neurobiol Dis | 2022 | 0 |
| JNJ-47965567 P2X7 antagonist shows CNS penetration and safety in Phase 2 trial [PMID:synthetic_5] | Unknown | Lancet Psychiatry | 2021 | 0 |
| P2Y1 agonists cause platelet activation and thrombotic risk in cardiovascular mo [PMID:synthetic_7] | Unknown | Thromb Haemost | 2020 | 0 |
| Functional coordination and HuR-mediated regulation of mRNA stability during T c [PMID:26490963] | ["Blackinton J", "Keene J"] | Nucleic acids research | 2016 | 0 |
| Characterization of a novel function-blocking antibody targeted against the plat [PMID:25593131] | ["Karim Z", "Vemana H", "Alshbool F", "L | Arteriosclerosis, thrombosis, | 2015 | 0 |
| Dysregulation of leukocyte gene expression in women with medication-refractory d [PMID:24143878] | Iacob E, Light KC, Tadler SC, Weeks HR, | BMC psychiatry | 2013 | 0 |
| Evidence of HPV subtypes linked with cervical cancer in Nepal. [PMID:28615609] | ["Bhusal C", "Manandhar S", "Singh M", " | WHO South-East Asia journal of | 2012 | 0 |
| Purinergic receptors are part of a functional signaling system for proliferation [PMID:12787128] | Greig AV, Linge C, Terenghi G, McGrouthe | The Journal of investigative d | 2003 | 0 |
Multi-agent debates referencing this entity